Mar 06 2025 11 mins
Lucence is leading a precision oncology company revolutionising cancer detection and treatment through their liquid biopsy technology.
Founded in 2016, they specialise in non-invasive genomic testing that analyses both DNA and RNA, delivering critical insights for personalised cancer care.
By advancing early detection and targeted therapy selection, Lucence empowers clinicians and patients with the correct tools to make informed, life-changing decisions.
On The Right Business, Hongbin Jeong speaks to Han, the Founding CEO and Medical Director of Lucence, to share more about their non-invasive cancer screening approach.
See omnystudio.com/listener for privacy information.